T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$2.81B |
| 2 |
Boeing
BA
|
+$1.68B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.33B |
| 4 |
Amphenol
APH
|
+$1.11B |
| 5 |
CME Group
CME
|
+$902M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$3.65B |
| 2 |
Advanced Micro Devices
AMD
|
+$2.51B |
| 3 |
UnitedHealth
UNH
|
+$2.06B |
| 4 |
Uber
UBER
|
+$1.84B |
| 5 |
Adobe
ADBE
|
+$1.44B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 33.21% |
| 2 | Healthcare | 12.77% |
| 3 | Consumer Discretionary | 11.71% |
| 4 | Financials | 11.15% |
| 5 | Communication Services | 9.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
Evertec
EVTC
$1.91B
| $21.7M | ﹤0.01% |
627,821
-784
| -0.1% | -$26.9K |
|
977
Alpha Metallurgical Resources
AMR
$1.97B
| $21.6M | ﹤0.01% |
108,075
-5,612
| -5% | -$1.26M |
|
|
DAWN
978
DELISTED
Day One Biopharmaceuticals
DAWN
| $21.6M | ﹤0.01% |
1,706,112
-838,751
| -33% | -$11.7M |
|
979
Aptiv
APTV
$10.2B
| $21.5M | ﹤0.01% |
355,062
-50,688
| -12% | -$3.1M |
|
|
MBX
980
MBX Biosciences
MBX
$3.23B
| $21.4M | ﹤0.01% |
1,161,527
-31,411
| -3% | -$669K |
|
981
Pricesmart
PSMT
$5.55B
| $21.4M | ﹤0.01% |
231,949
+201,841
| +670% | +$18.4M |
|
982
Alliant Energy
LNT
$18.2B
| $21.3M | ﹤0.01% |
360,348
+3,628
| +1% | +$219K |
|
983
TriNet
TNET
$3.22B
| $21.3M | ﹤0.01% |
234,462
+1,675
| +0.7% | +$155K |
|
984
Align Technology
ALGN
$12.5B
| $21.3M | ﹤0.01% |
102,033
-384
| -0.4% | -$85.8K |
|
985
Molson Coors Class B
TAP
$7.85B
| $21.2M | ﹤0.01% |
370,690
+2,745
| +0.7% | +$160K |
|
986
Tenable Holdings
TENB
$4.41B
| $21.1M | ﹤0.01% |
535,074
-139,275
| -21% | -$5.77M |
|
987
Amphastar Pharmaceuticals
AMPH
$858M
| $21M | ﹤0.01% |
566,656
-2,238
| -0.4% | -$102K |
|
988
Alcoa
AA
$13.1B
| $20.9M | ﹤0.01% |
553,045
-1,891,965
| -77% | -$78.6M |
|
989
Littelfuse
LFUS
$11.4B
| $20.7M | ﹤0.01% |
87,827
-28,765
| -25% | -$7.17M |
|
990
Rocket Lab Corp
RKLB
$51.2B
| $20.6M | ﹤0.01% |
807,521
+613,365
| +316% | +$10.8M |
|
991
Liberty Energy
LBRT
$3.45B
| $20.4M | ﹤0.01% |
1,023,031
-4,968
| -0.5% | -$91.9K |
|
992
Skyworks Solutions
SWKS
$10.5B
| $20.3M | ﹤0.01% |
228,757
-58,513
| -20% | -$5.32M |
|
|
RAPP
993
Rapport Therapeutics
RAPP
$2.27B
| $20.3M | ﹤0.01% |
1,143,384
+95,976
| +9% | +$2.13M |
|
994
Asbury Automotive
ABG
$3.78B
| $20.3M | ﹤0.01% |
83,321
-44,636
| -35% | -$10.9M |
|
995
Healthpeak Properties
DOC
$14.3B
| $20.1M | ﹤0.01% |
993,797
-1,448
| -0.1% | -$31.4K |
|
996
Invesco Senior Loan ETF
BKLN
$6.76B
| $20M | ﹤0.01% |
950,000
| – | – |
|
|
SNV
997
DELISTED
Synovus
SNV
| $19.9M | ﹤0.01% |
388,736
+115,465
| +42% | +$5.98M |
|
998
Zoom
ZM
$32.2B
| $19.5M | ﹤0.01% |
238,560
-264,487
| -53% | -$20.8M |
|
999
Iovance Biotherapeutics
IOVA
$2.95B
| $19.4M | ﹤0.01% |
2,628,101
-474,811
| -15% | -$4.4M |
|
1000
Carlisle Companies
CSL
$14.9B
| $19.3M | ﹤0.01% |
52,329
-5,174
| -9% | -$2.26M |
|
Similar funds
T. Rowe Price Associates's Q4 2024 Portfolio in Review
As of Q4 2024, T. Rowe Price Associates held 3,110 positions worth $867B, down 0.13% from $869B the previous quarter. Its ten largest holdings account for 35% of the portfolio.
T. Rowe Price Associates's Q4 2024 filing shows 92 new, 1,805 increased, 946 reduced and 96 closed positions. Its largest new stake was South Bow Corp: 12,337,055 shares worth $291M. The largest sale was Apple, an estimated $3.65B.
By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2024 buy was South Bow Corp: 12,337,055 shares worth $291M.
- T. Rowe Price Associates added most to Broadcom in Q4 2024, an estimated $2.81B increase.
- T. Rowe Price Associates's biggest Q4 2024 reduction was Apple, cutting an estimated $3.65B.
- T. Rowe Price Associates fully exited Tempus AI in Q4 2024, selling an estimated $292M.
- T. Rowe Price Associates's ten largest holdings make up 35% of its $867B portfolio in Q4 2024.
- T. Rowe Price Associates opened 92 new positions and closed 96 in Q4 2024.
- T. Rowe Price Associates's portfolio value fell 0.13% quarter-over-quarter to $867B.
Based on T. Rowe Price Associates's 13F filing for Q4 2024, filed 14 Feb 2025.